Results 211 to 220 of about 1,501,016 (387)

The Inflation Reduction Act and Etanercept

Arthritis &Rheumatology, EarlyView.
Charles L. Bennett, Jason B. Gibbons, Chadi Nabhan, Kenneth R. Carson, June M. McKoy, Kevin B. Knopf, Gerald Anderson   +6 more
wiley   +1 more source

Efficacy and Safety of ABBV‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial

Arthritis &Rheumatology, Accepted Article.
Objective Despite availability of biologics and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit, Atul Singhal, Alan Kivitz, Edit Drescher, Yoshinori Taniguchi, Rosalía Martínez Pérez, Jaclyn Anderson, Ronilda D'Cunha, Weihan Zhao, Nicholas DeVogel, Julie Parmentier, Romy Christmann, Dilek Arikan, Howard Amital   +13 more
wiley   +1 more source

A Comparison of Betahistine Hydrochloride With Placebo for Vertebral-Basilar Insufficiency: A Double-Blind Study [PDF]

, 1975
JAMES H. SPRUILL, James F. Toole, William Kitto, Hersey E. Miller   +3 more
openalex   +1 more source

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

New England Journal of Medicine, 2017
M. Wechsler, P. Akuthota, D. Jayne, P. Khoury, A. Klion, C. Langford, P. Merkel, F. Moosig, U. Specks, M. Cid, R. Luqmani, Judith E. Brown, S. Mallett, R. Philipson, S. Yancey, J. Steinfeld, P. Weller, G. Gleich   +17 more
semanticscholar   +1 more source

Expert Perspective: Diagnosis and Treatment of Castleman Disease

Arthritis &Rheumatology, Accepted Article.
Summary Castleman disease (CD) is a major diagnostic challenge for Rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y.C. Chen, Lu Zhang, David C. Fajgenbaum   +2 more
wiley   +1 more source

Generalisation of Placebo and Nocebo Effects: Current Knowledge and Future Directions. [PDF]

Eur J Pain
Weng L, Peerdeman KJ, van Laarhoven AIM, Evers AWM.   +3 more
europepmc   +1 more source

Role of pain in placebo analgesia.

, 1979
J.D. Levine, Newton C. Gordon, Joel C. Bornstein, H. L. Fields   +3 more
openalex   +1 more source

Pharmacodynamic Effects of Litifilimab in Lupus in the LILAC Phase II Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines

Arthritis &Rheumatology, Accepted Article.
Objective The pharmacodynamic effects of litifilimab on type I interferon (IFN) response and correlations with clinical outcomes were investigated in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Methods Participants from Part A (SLE) or Part B (CLE with/without SLE) of the randomized phase II LILAC trial who received ...
Richard Furie, Victoria P. Werth, Eric Milliman, Kyle Ferber, Roland Brown, Jad Zoghbi, Nathalie Franchimont, Youmna Lahoud, Catherine Barbey   +8 more
wiley   +1 more source

A randomized crossover trial with experience sampling to test placebo effects on pathological skin-picking. [PDF]

Sci Rep
Schienle A, Kohlhofer S, Wilhelm J, Tanzmeister S.   +3 more
europepmc   +1 more source

Non-specific urethritis. A placebo-controlled trial of minocycline in conjunction with laboratory investigations.

, 1976
M J Prentice, D Taylor‐Robinson, G. W. Csonka   +2 more
openalex   +1 more source